Table 2.
Demographic and clinical characteristics of pulmonary embolism admissions according to kidney function
| Normal Kidney Function | CKD | ESRD | |
|---|---|---|---|
| Pulmonary embolism (n) | 142,338 | 9920 | 1600 |
| Age (yr), mean ± SD | 62.3±17.3 | 73.1±13.3a | 59.6±17.2a |
| Age (yr), n (%) | |||
| 20–44 | 24,766 (17.4) | 397 (4.0)a | 361 (22.6)a |
| 45–54 | 22,191 (15.6) | 605 (6.1)a | 232 (14.5) |
| 55–64 | 25,819 (18.1) | 1328 (13.4)a | 272 (17.0) |
| 65–74 | 28,113 (19.8) | 2370 (23.9)a | 374 (23.4) |
| ≥75 | 41,447 (29.1) | 5220 (52.6)a | 360 (22.5)a |
| Sex, n (%) | |||
| Male | 63,791(44.8) | 5188 (52.3) | 713(44.5) |
| Race, n (%) | |||
| White | 76,731 (53.9) | 5202 (52.4) | 465 (29.1)a |
| Black | 15,793 (11.1) | 1470 (14.8) | 532 (33.2)a |
| Hispanic | 5226 (3.6) | 330 (3.3) | 67 (4.1) |
| Asian | 860 (0.6) | 77 (0.8) | 29 (1.8)a |
| Native American | 502 (0.4) | 31 (0.3) | 19 (1.2)a |
| Other | 2083 (1.5) | 91 (0.9) | 30 (1.9) |
| Unknown | 41,143 (28.9) | 2718 (27.4) | 457 (28.5) |
| Charlson–Deyo's comorbidity score, n (%) | |||
| 0 | 63,387 (44.5) | 2806 (28.2)a | 457 (28.5)a |
| 1–2 | 57,256 (40.2) | 5190 (52.3)a | 811 (50.7)a |
| 3–4 | 8426 (5.9) | 1294 (13.0)a | 207 (12.9)a |
| 5–6 | 2912 (2.0) | 148 (1.5) | 58 (3.6) |
| ≥7 | 10,355 (7.3) | 480 (4.8) | 67 (4.2) |
| Severe pulmonary embolism, n (%) | 3951 (2.8) | 429(4.3)a | 89 (5.5)a |
| Comorbidities (%) | |||
| Diabetes mellitus | 18.1 | 34.2a | 38a |
| Hypertension | 49.6 | 74.5a | 92.5a |
| Congestive heart failure | 10.0 | 43.1a | 33.3a |
| Morbid obesity | 5.6 | 5.5 | 4.0 |
| Smoking | 20.5 | 11.5a | 8.8a |
| Chronic obstructive pulmonary disease | 15.8 | 24.2a | 17.0 |
| Cancer | 23.5 | 21.3 | 13.2a |
| Hypercoagulable state | 3.9 | 2.0a | 1.8a |
| Cirrhosis | 1.5 | 1.1 | 1.3 |
a
Significant difference at P<0.05 between the variable compared with normal kidney function using the chi-squared test.